TCRT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Alaunos Therapeutics Inc (TCRT).


$3.05M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

TCRT Market Cap. (MRY)


TCRT Shares Outstanding (MRY)


TCRT Assets (MRY)


Total Assets

$2.75M

Total Liabilities

$692.00K

Total Investments

$0

TCRT Income (MRY)


Revenue

$10.00K

Net Income

-$4.68M

Operating Expense

$4.82M

TCRT Cash Flow (MRY)


CF Operations

-$4.97M

CF Investing

$0

CF Financing

$0

TCRT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TCRT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$2,755,000 (-66.66%)

$8,263,000 (-87.28%)

$64,937,000 (-31.55%)

$94,865,000 (-35.18%)

Assets Current

$2,755,000 (-66.65%)

$8,261,000 (-84.64%)

$53,799,000 (-31.75%)

$78,831,000 (-39.63%)

Assets Non-Current

$0 (0%)

$2,000 (-99.98%)

$11,138,000 (-30.54%)

$16,034,000 (1.76%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$2,063,000 (-67.29%)

$6,307,000 (-83.64%)

$38,555,000 (-33.59%)

$58,057,000 (-53.17%)

Property Plant & Equipment Net

$0 (0%)

$2,000 (-99.98%)

$10,596,000 (-31.02%)

$15,361,000 (3.23%)

Cash & Equivalents

$1,091,000 (-82.00%)

$6,062,000 (-88.57%)

$53,038,000 (-30.30%)

$76,096,000 (-33.94%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$5,000 (400.00%)

$1,000 (-75.00%)

$4,000 (-99.64%)

$1,111,000 (-76.18%)

Trade & Non-Trade Payables

$516,000 (-16.23%)

$616,000 (-55.65%)

$1,389,000 (1.54%)

$1,368,000 (42.50%)

Accumulated Retained Earnings (Deficit)

-$920,446,000 (-0.51%)

-$915,767,000 (-3.99%)

-$880,627,000 (-4.48%)

-$842,852,000 (-10.31%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$19,511,000 (-33.56%)

$29,365,000 (635.04%)

Debt Current

$0 (0%)

$0 (0%)

$17,323,000 (101.50%)

$8,597,000 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$2,188,000 (-89.46%)

$20,768,000 (419.85%)

Total Liabilities

$692,000 (-64.62%)

$1,956,000 (-92.59%)

$26,382,000 (-28.33%)

$36,809,000 (64.60%)

Liabilities Current

$692,000 (-64.62%)

$1,956,000 (-91.91%)

$24,166,000 (50.65%)

$16,041,000 (-12.67%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$2,216,000 (-89.33%)

$20,768,000 (419.85%)

TCRT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$10,000 (100.00%)

$5,000 (-99.83%)

$2,922,000 (634.17%)

$398,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,460,000 (-63.50%)

$12,219,000 (-7.02%)

$13,142,000 (-52.32%)

$27,564,000 (-0.37%)

Research & Development Expense

$362,000 (-97.78%)

$16,279,000 (-34.93%)

$25,018,000 (-49.60%)

$49,643,000 (-5.79%)

Operating Expenses

$4,822,000 (-85.93%)

$34,272,000 (-10.19%)

$38,160,000 (-51.04%)

$77,947,000 (-3.00%)

Interest Expense

$0 (0%)

$1,921,000 (-39.09%)

$3,154,000 (165.26%)

$1,189,000 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$4,679,000 (86.68%)

-$35,140,000 (6.86%)

-$37,730,000 (52.09%)

-$78,751,000 (1.53%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$4,679,000 (86.68%)

-$35,140,000 (6.86%)

-$37,730,000 (52.09%)

-$78,751,000 (1.53%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$4,679,000 (86.68%)

-$35,140,000 (6.86%)

-$37,730,000 (52.09%)

-$78,751,000 (1.53%)

Weighted Average Shares

$1,601,252 (-89.99%)

$15,995,323 (-92.63%)

$217,130,311 (1.27%)

$214,399,074 (2.27%)

Weighted Average Shares Diluted

$1,601,252 (-89.99%)

$15,995,323 (-92.63%)

$217,130,311 (1.27%)

$214,399,074 (2.27%)

Earning Before Interest & Taxes (EBIT)

-$4,679,000 (85.91%)

-$33,219,000 (3.92%)

-$34,576,000 (55.42%)

-$77,562,000 (3.02%)

Gross Profit

$10,000 (100.00%)

$5,000 (-99.83%)

$2,922,000 (634.17%)

$398,000 (0%)

Operating Income

-$4,812,000 (85.96%)

-$34,267,000 (2.76%)

-$35,238,000 (54.56%)

-$77,549,000 (3.50%)

TCRT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$1,346,000 (797.41%)

-$193,000 (94.19%)

-$3,323,000 (66.02%)

Net Cash Flow from Financing

$0 (0%)

-$18,138,000 (-384.88%)

$6,367,000 (-75.30%)

$25,776,000 (-74.76%)

Net Cash Flow from Operations

-$4,971,000 (83.51%)

-$30,142,000 (-3.11%)

-$29,232,000 (52.44%)

-$61,468,000 (-7.81%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,971,000 (89.41%)

-$46,934,000 (-103.55%)

-$23,058,000 (40.90%)

-$39,015,000 (-210.44%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$1,346,000 (797.41%)

-$193,000 (94.19%)

-$3,323,000 (66.02%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$18,230,000 (-118.77%)

-$8,333,000 (-133.68%)

$24,740,000 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$92,000 (-99.37%)

$14,700,000 (1318.92%)

$1,036,000 (-98.99%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$435,000 (-84.46%)

$2,800,000 (-20.63%)

$3,528,000 (-67.25%)

$10,774,000 (57.77%)

Depreciation Amortization & Accretion

$2,000 (-99.92%)

$2,601,000 (-49.75%)

$5,176,000 (130.56%)

$2,245,000 (99.02%)

TCRT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-46790.00% (93.34%)

-702800.00% (-54329.99%)

-1291.20% (93.47%)

-19786.70%

EBITDA Margin

-46770.00% (92.36%)

-612360.00% (-60758.68%)

-1006.20% (94.68%)

-18923.90%

Return on Average Equity (ROAE)

-140.10% (28.88%)

-197.00% (-108.91%)

-94.30% (3.97%)

-98.20% (-88.12%)

Return on Average Assets (ROAA)

-110.00% (18.40%)

-134.80% (-160.23%)

-51.80% (27.04%)

-71.00% (-53.68%)

Return on Sales (ROS)

-46790.00% (92.96%)

-664380.00% (-56046.37%)

-1183.30% (93.93%)

-19487.90%

Return on Invested Capital (ROIC)

-471.10% (35.98%)

-735.90% (-188.36%)

-255.20% (27.06%)

-349.90% (41.60%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.65 (-35.27%)

-0.48 (87.38%)

-3.82 (-29.60%)

-2.95 (55.58%)

Price to Sales Ratio (P/S)

305.04 (-91.01%)

3,392.62 (6933.68%)

48.23 (-91.79%)

587.17

Price to Book Ratio (P/B)

1.48 (-45.16%)

2.7 (-25.91%)

3.64 (-10.30%)

4.06 (-6.84%)

Debt to Equity Ratio (D/E)

0.34 (8.06%)

0.31 (-54.68%)

0.68 (7.89%)

0.63 (252.22%)

Earnings Per Share (EPS)

-2.92 (-32.73%)

-2.2 (-1194.12%)

-0.17 (54.05%)

-0.37 (2.63%)

Sales Per Share (SPS)

0.01 (0%)

0 (0%)

0.01 (550.00%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-3.1 (-72.44%)

-1.8 (-1223.53%)

-0.14 (54.97%)

-0.3 (5.33%)

Book Value Per Share (BVPS)

1.29 (226.90%)

0.39 (121.35%)

0.18 (-34.32%)

0.27 (-54.15%)

Tangible Assets Book Value Per Share (TABVPS)

1.72 (232.88%)

0.52 (72.91%)

0.3 (-32.35%)

0.44 (-36.68%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-3 (-50.00%)

-2 (60.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.29 (-43.14%)

-0.2 (94.74%)

-3.88 (-69.51%)

-2.29 (55.55%)

Asset Turnover

0 (0%)

0 (0%)

0.04 (900.00%)

0 (0%)

Current Ratio

3.98 (-5.73%)

4.22 (89.71%)

2.23 (-54.70%)

4.91 (-30.89%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$4,971,000 (82.74%)

-$28,796,000 (2.14%)

-$29,425,000 (54.58%)

-$64,791,000 (2.99%)

Enterprise Value (EV)

$1,367,385 (-78.08%)

$6,239,333 (-94.53%)

$114,080,763 (-33.84%)

$172,427,950 (-57.54%)

Earnings Before Tax (EBT)

-$4,679,000 (86.68%)

-$35,140,000 (6.86%)

-$37,730,000 (52.09%)

-$78,751,000 (1.53%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$4,677,000 (84.72%)

-$30,618,000 (-4.14%)

-$29,400,000 (60.96%)

-$75,317,000 (4.48%)

Invested Capital

$972,000 (296.73%)

$245,000 (-96.62%)

$7,244,000 (-77.43%)

$32,093,000 (91.34%)

Working Capital

$2,063,000 (-67.28%)

$6,305,000 (-78.72%)

$29,633,000 (-52.81%)

$62,790,000 (-44.05%)

Tangible Asset Value

$2,755,000 (-66.66%)

$8,263,000 (-87.28%)

$64,937,000 (-31.55%)

$94,865,000 (-35.18%)

Market Capitalization

$3,050,385 (-82.07%)

$17,012,333 (-87.88%)

$140,323,763 (-40.44%)

$235,598,950 (-56.37%)

Average Equity

$3,338,750 (-81.29%)

$17,841,500 (-55.39%)

$39,992,500 (-50.12%)

$80,171,500 (-47.66%)

Average Assets

$4,255,000 (-83.68%)

$26,067,000 (-64.19%)

$72,800,750 (-34.39%)

$110,966,000 (-35.88%)

Invested Capital Average

$993,250 (-78.00%)

$4,514,250 (-66.68%)

$13,547,750 (-38.88%)

$22,164,500 (66.03%)

Shares

1,601,252 (-90.02%)

16,041,804 (-92.58%)

216,182,042 (0.02%)

216,145,826 (0.87%)